Covid vaccine: more hope and caution as US biotech firm, Moderna, announces new vaccine candidate

Moderna, a US-based biotech company, has released promising preliminary data from their COVID-19 vaccine trial, moving forward with requesting ‘emergency-use’ approval from the US Food and Drug Administration. Their announcement comes just a week after a similar statement from Pfizer and BioNTech, joining them as trailblazers in the pharmaceutical arena challenging the antigens of this … Continue reading Covid vaccine: more hope and caution as US biotech firm, Moderna, announces new vaccine candidate